Adam W. Mailloux - Concepedia

Author

Adam W. Mailloux

Also Known As

A Mailloux, A. Mailloux, A. W. Mailloux, A.W. Mailloux, Adam Mailloux, Adam W Mailloux, Adam W. Mailloux, Adam William Mailloux, Coleman, Michael F.

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Moffitt Cancer Center Medical University of South Carolina Cleveland Clinic Tianjin Medical University Cancer Institute and Hospital University of South Florida

About

Adam W. Mailloux is an author at Moffitt Cancer Center specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	243
2	Cell Biology	4	4	117
3	Health Sciences	2	2	59
4	Social Sciences	2	2	45
5	Biostatistics	1	1	41

Adam W. Mailloux

Publications

971

Citations

H-Index

Page 1

	Year	Citations
GM-CSF–dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia Eric Padron, Jeffrey S. Painter, Sateesh Kunigal, Blood	2013	154
STING Signaling in Melanoma Cells Shapes Antigenicity and Can Promote Antitumor T-cell Activity Rana Falahat, Patricio Perez-Villarroel, Adam W. Mailloux, Cancer Immunology Research	2019	87
Expansion of Effector Memory Regulatory T Cells Represents a Novel Prognostic Factor in Lower Risk Myelodysplastic Syndrome Adam W. Mailloux, Chiharu Sugimori, Rami S. Komrokji, The Journal of Immunology	2012	83
NK-Dependent Increases in CCL22 Secretion Selectively Recruits Regulatory T Cells to the Tumor Microenvironment Adam W. Mailloux, Matthew R. Young The Journal of Immunology	2009	82
Overexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice Crystina L. Kriss, Javier Pinilla‐Ibarz, Adam W. Mailloux, Blood	2012	75
Induction of Tertiary Lymphoid Structures With Antitumor Function by a Lymph Node-Derived Stromal Cell Line Genyuan Zhu, Satoshi Nemoto, Adam W. Mailloux, Frontiers in Immunology	2018	74
Tumor-Associated Tertiary Lymphoid Structures: Gene-Expression Profiling and Their Bioengineering Genyuan Zhu, Rana Falahat, Kui Wang, Frontiers in Immunology Gene-expression ProfilingImmunologyImmunotherapyTumor BiologySynthetic Immunology	2017	58
Efficacy of ALK5 inhibition in myelofibrosis Lanzhu Yue, Matthias Bartenstein, Wanke Zhao, JCI Insight	2017	47
A phase II multicenter rabbit anti-thymocyte globulin trial in patients with myelodysplastic syndromes identifying a novel model for response prediction Rami S. Komrokji, Adam W. Mailloux, D.-T. Chen, Haematologica ImmunohematologyImmunologyPathologyImmunotherapyAplastic Anemia	2014	41
A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic Syndromes Rami S. Komrokji, Sheng Wei, Adam W. Mailloux, Clinical Lymphoma Myeloma & Leukemia Hematological MalignancyBone Marrow FailureMedicineMalignant Blood DisorderHematology	2018	40

Page 1